FDA Increases Invokana Warning
On September 10th, the U.S. Food and Drug Administration (FDA) released an increased warning as it pertains to the diabetes drug Invokana (canagliflozin). This dangerous drug is used to treat Type 2 Diabetes, but in reality poses an increased risk to those who take it for decreases in bone density and an increase in the chances of bone fractures.
Although the bone-related potential side effects of Invokana were already known and listed on the label of this drug, the FDA’s increased warning signals an added danger to those taking Invokana. The FDA’s warning was issued after a mandated trial period after approval of the drug, and reflects data received from nine individual clinical trials. These trials and information recently released by the FDA warn that the side effects of Invokana can occur as soon as 12 weeks (3 months) after starting to take the drug.
No FDA Recall for Invokana – Yet
The FDA has not issued a recall on Invokana. Instead, it is urging doctors who are considering prescribing the drug to consider the potential side effect of bone fractures with more weight and discuss this danger with their patients. According to the FDA, those taking Invokana should not stop taking it unless they have discussed an alternative plan for controlling blood sugar with their doctor.
What Does This Mean For Those Harmed By Invokana?
As of now, no national recall has been instituted for Invokana, and the drug is still being used to treat Type 2 Diabetes. However, there is a very real possibility that those taking the drug have (or will) experience some of the dangerous side effects that could lead to difficulties with bone density or bone fractures. The additional treatment of these injuries could cause additional medical bills, long-term health concerns, and potentially inability to work. Those injured by Invokana or any other harmful drug should consider the possibility of seeking financial compensation for these damages through a product liability lawsuit.
The theory behind product liability lawsuits from defective drugs is simple: a harmed individual or group of individuals file a civil lawsuit in order to recover the financial damages the drug has caused from the corporation that produces and markets the drug. The actual process of filing and bringing such a claim to fruition, however, can be complex and requires the help of an experienced defective drug attorney. This is why the knowledgable and aggressive lawyers of the Olinde Law Firm focus on helping people recover the financial compensation they deserve in defective drug lawsuits.
Product Liability and Defective Drug Attorneys Handling Pharmaceutical Litigation
If you or a loved one has been harmed as the result of taking a defective drug, please call our New Orleans, LA offices to discuss your legal options. While we cannot guarantee success in each instance, we will work tirelessly on your behalf to reach the best possible outcome in your case. Contact our office for a free, no-obligation consultation about your potential claim by calling 1-800-587-1889 or through the form on our contact page. We proudly represent clients throughout the state of Louisiana and nationwide in product liability and defective drug cases.